Clover Health Investments (CLOV) vs Humana (HUM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Clover Health Investments (CLOV) has outperformed Humana (HUM) over the past year, gaining 68.9% versus a gain of 37.9%. Over five years, HUM leads with a -7.7% price change compared with -42.4% for CLOV. Humana is the larger company by market cap ($47.61 billion vs $2.42 billion), about 19.7 times the size.
On valuation, Humana trades at a lower forward P/E (23.9x vs 30.4x for Clover Health Investments). Humana pays a dividend yielding 0.89%, while Clover Health Investments does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLOV | HUM |
|---|---|---|
| Share price | $4.56 | $396.51 |
| Market cap | $2.42B | $47.61B |
| 1-day change | -0.87% | -1.92% |
| YTD return | +94.04% | +58.91% |
| 1-year return | +68.89% | +37.86% |
| 5-year return | -42.35% | -7.71% |
| P/E ratio (TTM) | — | 37.48 |
| Forward P/E | 30.40 | 23.90 |
| EPS (TTM) | $-0.05 | $10.58 |
| Dividend yield | 0.00% | 0.89% |
| Annual dividend | $0.00 | $3.54 |
| Revenue (latest FY) | — | $129.66B |
| Revenue growth (YoY) | — | +10.11% |
| Net income (latest FY) | — | $1.19B |
| Operating margin | — | 2.09% |
| Net margin | — | 0.92% |
| 52-week high | $5.59 | $428.88 |
| 52-week low | $1.58 | $163.11 |
| Distance from 52-week high | -18.43% | -7.55% |
| Analyst consensus | none | buy |
| Avg. price target upside | +17.98% | +6.87% |
| Average volume | 4.27M | 1.23M |
| Shares outstanding | 435.44M | 120.08M |
| Employees | 724 | 67,060 |
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Plans | Healthcare Plans |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Humana is about 19.7 times larger than Clover Health Investments by market value ($47.61B vs $2.42B).
- CLOV has outperformed HUM by 31.0 percentage points over the past year.
About Clover Health Investments
CLOV stock →Clover Health Investments, Corp. provides medicare advantage plans in the United States.
Healthcare · Healthcare Plans · 724 employees
About Humana
HUM stock →Humana Inc. provides medical and specialty insurance products in the United States.
Healthcare · Healthcare Plans · 67,060 employees
CLOV vs HUM FAQ
Which is bigger, Clover Health Investments or Humana?
Humana (HUM) is larger, with a market capitalization of $47.61B compared with $2.42B for Clover Health Investments (CLOV).
Which stock has performed better over the past year, CLOV or HUM?
CLOV returned +68.89% over the past 12 months, compared with +37.86% for HUM (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Clover Health Investments or Humana?
Humana pays a dividend yielding 0.89%, while Clover Health Investments does not currently pay a regular dividend.
Are Clover Health Investments and Humana in the same industry?
Yes. Both are classified in the Healthcare Plans industry within the Healthcare sector.